MHC Class II Presentation in Autoimmunity

  • Cells. 2023 Jan 14;12(2):314. doi: 10.3390/cells12020314.
Irina A Ishina  1 Maria Y Zakharova  1 Inna N Kurbatskaia  1 Azad E Mamedov  1 Alexey A Belogurov Jr  1  2 Alexander G Gabibov  1  3  4
Affiliations
  • 1. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 117997 Moscow, Russia.
  • 2. Department of Biological Chemistry, Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.
  • 3. Department of Life Sciences, Higher School of Economics, 101000 Moscow, Russia.
  • 4. Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Abstract

Antigen presentation by major histocompatibility complex class II (MHC-II) molecules is crucial for eliciting an efficient immune response by CD4+ T cells and maintaining self-antigen tolerance. Some MHC-II alleles are known to be positively or negatively associated with the risk of the development of different autoimmune diseases (ADs), including those characterized by the emergence of autoreactive T cells. Apparently, the MHC-II presentation of self-antigens contributes to the autoimmune T cell response, initiated through a breakdown of central tolerance to self-antigens in the thymus. The appearance of autoreactive T cell might be the result of (i) the unusual interaction between T cell receptors (TCRs) and self-antigens presented on MHC-II; (ii) the posttranslational modifications (PTMs) of self-antigens; (iii) direct loading of the self-antigen to classical MHC-II without additional nonclassical MHC assistance; (iv) the proinflammatory environment effect on MHC-II expression and antigen presentation; and (v) molecular mimicry between foreign and self-antigens. The peculiarities of the processes involved in the MHC-II-mediated presentation may have crucial importance in the elucidation of the mechanisms of triggering and developing ADs as well as for clarification on the protective effect of MHC-II alleles that are negatively associated with ADs.

Keywords
antigen presentation; autoimmune diseases; autoreactive T cells; central tolerance; human leukocyte antigen; major histocompatibility complex; negative selection; thymus.